Asha Adem
Angiogenesis Foundation(US)
Publications by Year
Research Areas
Pancreatic function and diabetes, Endoplasmic Reticulum Stress and Disease, Neuroendocrine Tumor Research Advances, RNA Interference and Gene Delivery, Neuroblastoma Research and Treatments
Most-Cited Works
- → Recapitulation of Pancreatic Neuroendocrine Tumors in Human Multiple Endocrine Neoplasia Type I Syndrome via Pdx1 -Directed Inactivation of Men1(2009)82 cited
- → Tumor vasculature‐targeted delivery of tumor necrosis factor‐α*(2008)81 cited
- → Filamin A interacting protein 1‐like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis(2013)69 cited
- → Multiple Endocrine Neoplasia Type 1 Deletion in Pancreatic α-Cells Leads to Development of Insulinomas in Mice(2010)54 cited
- → AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas(2016)52 cited
- → Functional Characterization of Filamin A Interacting Protein 1–Like, a Novel Candidate for Antivascular Cancer Therapy(2008)47 cited
- → Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model(2012)44 cited
- → Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity(2012)40 cited
- → Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations(2009)36 cited
- → Loss ofMEN1activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis(2016)35 cited